Anti-hyperalgesic effects of anti-serotonergic compounds on serotonin- and capsaicin-evoked thermal hyperalgesia in the rat

Neuroscience

Volumn 203, Issue , 2012, Pages 207-215

  Loyd, D R ^a   Chen, P B ^a   Hargreaves, K M ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

5HT; 5HT receptors; Granisetron; Hyperalgesia; Ketanserin; Sumatriptan

Indexed keywords

CAPSAICIN; GRANISETRON; KETANSERIN; SEROTONIN; SEROTONIN ANTAGONIST; SUMATRIPTAN; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HYPERALGESIA; IN VIVO STUDY; MALE; NOCICEPTIVE STIMULATION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEX DIFFERENCE; THERMAL ANALYSIS; THERMAL INJURY; THERMAL STIMULATION; WITHDRAWAL REFLEX;

ANIMALS; CAPSAICIN; FEMALE; HYPERALGESIA; KETANSERIN; MALE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; SUMATRIPTAN;

EID: 84856427628     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.12.019     Document Type: Article

References (53)

1. Akiyama T., Carstens M.I., Carstens E. Facial injections of pruritogens and algogens excite partly overlapping populations of primary and second-order trigeminal neurons in mice. J Neurophysiol 2010, 104:2442-2450.
2. Babenko V., Svensson P., Graven-Nielsen T., Drewes A.M., Jensen T.S., Arendt-Nielsen L. Duration and distribution of experimental muscle hyperalgesia in humans following combined infusions of serotonin and bradykinin. Brain Res 2000, 853:275-281.
3. Berman N.E., Puri V., Chandrala S., Puri S., Macgregor R., Liverman C.S., Klein R.M. Serotonin in trigeminal ganglia of female rodents: relevance to menstrual migraine. Headache 2006, 46:1230-1245.
4. Bingham S., Davey P.T., Sammons M., Raval P., Overend P., Parsons A.A. Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT(1B/1D) receptors. Exp Neurol 2001, 167:65-73.
5. Brennan F., Carr D.B., Cousins M. Pain management: a fundamental human right. Anesth Analg 2007, 105:205-221.
6. Carmichael N.M., Charlton M.P., Dostrovsky J.O. Activation of the 5-HT1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin. Pain 2008, 134:97-105.
7. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313.
8. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
9. Cesare P., Moriondo A., Vellani V., McNaughton P.A. Ion channels gated by heat. Proc Natl Acad Sci U S A 1999, 96:7658-7663.
10. Chen L.C., Ashcroft D.M. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 2008, 48:236-247.
11. Cremonini F., Delgado-Aros S., Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 2003, 15:79-86.
12. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000, 405:183-187.
13. Diamond S., Freitag F.G., Feoktistov A., Nissan G. Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans. J Headache Pain 2007, 8:13-18.
14. Doak G.J., Sawynok J. Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes. Neuroscience 1997, 80:939-949.
15. Durham P.L., Russo A.F. Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci 1999, 19:3423-3429.
16. Ernberg M., Hedenberg-Magnusson B., Kurita H., Kopp S. Effects of local serotonin administration on pain and microcirculation in the human masseter muscle. J Orofac Pain 2006, 20:241-248.
17. Ernberg M., Lundeberg T., Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain 2000, 84:339-346.
18. Ernberg M., Lundeberg T., Kopp S. Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain 2000, 85:31-39.
19. Ernberg M., Voog U., Alstergren P., Lundeberg T., Kopp S. Plasma and serum serotonin levels and their relationship to orofacial pain and anxiety in fibromyalgia. J Orofac Pain 2000, 14:37-46.
20. Ferrari M.D., Roon K.I., Lipton R.B., Goadsby P.J. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001, 358:1668-1675.
21. Gilchrist H.D., Allard B.L., Simone D.A. Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats. Pain 1996, 67:179-188.
22. Gundlah C., Pecins-Thompson M., Schutzer W.E., Bethea C.L. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Brain Res Mol Brain Res 1999, 63:325-339.
23. Hargreaves R.J., Shepheard S.L. Pathophysiology of migraine-new insights. Can J Neurol Sci 1999, 26(Suppl 3):S12-S19.
24. Häuser W., Bernardy K., Uçeyler N., Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 2009, 301:198-209.
25. Herken H., Erdal E., Mutlu N., Barlas O., Cataloluk O., Oz F., Güray E. Possible association of temporomandibular joint pain and dysfunction with a polymorphism in the serotonin transporter gene. Am J Orthod Dentofacial Orthop 2001, 120:308-313.
26. Jinks S.L., Carstens E. Responses of superficial dorsal horn neurons to intradermal serotonin and other irritants: comparison with scratching behavior. J Neurophysiol 2002, 87:1280-1289.
27. Kanai A., Saito M., Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache 2006, 46:577-582. discussion:583-574.
28. Klein A.H., Sawyer C.M., Zanotto K.L., Ivanov M.A., Cheung S., Carstens M.I., Furrer S., Simons C.T., Slack J.P., Carstens E. A tingling sanshool derivative excites primary sensory neurons and elicits nocifensive behavior in rats. J Neurophysiol 2011, 105:1701-1710.
29. Kopp S. The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation. J Oral Maxillofac Surg 1998, 56:189-191.
30. Loyd D.R., Weiss G., Henry M.A., Hargreaves K.M. Serotonin increases the functional activity of capsaicin-sensitive rat trigeminal nociceptors via peripheral serotonin receptors. Pain 2011, 152(10):2267-2276.
31. Moskowitz M.A., Buzzi M.G. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 1991, 238(Suppl 1):S18-S22.
32. Nakajima K., Obata H., Ito N., Goto F., Saito S. The nociceptive mechanism of 5-hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats. Eur J Pain 2009, 13:441-447.
33. Nikai T., Basbaum A.I., Ahn A.H. Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain 2008, 139:533-540.
34. Obata H., Saito S., Ishizaki K., Goto F. Antinociception in rat by sarpogrelate, a selective 5-HT(2A) receptor antagonist, is peripheral. Eur J Pharmacol 2000, 404:95-102.
35. Ohta T., Ikemi Y., Murakami M., Imagawa T., Otsuguro K., Ito S. Potentiation of transient receptor potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons. J Physiol 2006, 576:809-822.
36. Okamoto K., Imbe H., Morikawa Y., Itoh M., Sekimoto M., Nemoto K., Senba E. 5-HT2A receptor subtype in the peripheral branch of sensory fibers is involved in the potentiation of inflammatory pain in rats. Pain 2002, 99:133-143.
37. Okamoto K., Imbe H., Tashiro A., Kimura A., Donishi T., Tamai Y., Senba E. The role of peripheral 5HT2A and 5HT1A receptors on the orofacial formalin test in rats with persistent temporomandibular joint inflammation. Neuroscience 2005, 130:465-474.
38. Parada C.A., Tambeli C.H., Cunha F.Q., Ferreira S.H. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience 2001, 102:937-944.
39. Patwardhan A.M., Jeske N.A., Price T.J., Gamper N., Akopian A.N., Hargreaves K.M. The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc Natl Acad Sci U S A 2006, 103:11393-11398.
40. Pingle S.C., Matta J.A., Ahern G.P. Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb Exp. Pharmacol 2007, (179):155-171.
41. Qin H.Y., Luo J.L., Qi S.D., Xu H.X., Sung J.J., Bian Z.X. Visceral hypersensitivity induced by activation of transient receptor potential vanilloid type 1 is mediated through the serotonin pathway in rat colon. Eur J Pharmacol 2010, 647:75-83.
42. Sasaki M., Obata H., Kawahara K., Saito S., Goto F. Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats. Pain 2006, 122:130-136.
43. Sommer C. Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol 2004, 30:117-125.
44. Sufka K.J., Schomburg F.M., Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 1992, 41:53-56.
45. Sugiuar T., Bielefeldt K., Gebhart G.F. TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation. J Neurosci 2004, 24:9521-9530.
46. Sung D., Dong X., Ernberg M., Kumar U., Cairns B.E. Serotonin (5-HT) excites rat masticatory muscle afferent fibers through activation of peripheral 5-HT3 receptors. Pain 2008, 134:41-50.
47. Taiwo Y.O., Levine J.D. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 1992, 48:485-490.
48. Tokunaga A., Saika M., Senba E. 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain 1998, 76:349-355.
49. Ullmer C., Schmuck K., Kalkman H.O., Lübbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 1995, 370:215-221.
50. Vera-Portocarrero L.P., Ossipov M.H., King T., Porreca F. Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan. Gastroenterology 2008, 135:1369-1378.
51. Voets T., Droogmans G., Wissenbach U., Janssens A., Flockerzi V., Nilius B. The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature 2004, 430:748-754.
52. Zeitz K.P., Guy N., Malmberg A.B., Dirajlal S., Martin W.J., Sun L., Bonhaus D.W., Stucky C.L., Julius D., Basbaum A.I. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002, 22:1010-1019.
53. Zhang L., Ma W., Barker J.L., Rubinow D.R. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience 1999, 94:251-259.